Global Patent Index - EP 2632454 A1

EP 2632454 A1 20130904 - HIV INTEGRASE INHIBITORS

Title (en)

HIV INTEGRASE INHIBITORS

Title (de)

HIV-INTEGRASE-HEMMER

Title (fr)

INHIBITEURS D'INTÉGRASE DE VIH

Publication

EP 2632454 A1 20130904 (EN)

Application

EP 11836929 A 20111025

Priority

  • US 40811410 P 20101029
  • US 2011057557 W 20111025

Abstract (en)

[origin: WO2012058173A1] Tricyclic compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: (I), wherein R1A, R1B, R1C, R2A, R2B, R3A, R3B, R4, R5 and R6 are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

IPC 8 full level

A61K 31/235 (2006.01); A61K 31/66 (2006.01)

CPC (source: EP)

A61K 31/235 (2013.01); A61K 31/66 (2013.01); A61K 45/06 (2013.01); A61P 31/18 (2017.12)

Citation (search report)

See references of WO 2012058173A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2012058173 A1 20120503; AU 2011320651 A1 20130502; CA 2814703 A1 20120503; EP 2632454 A1 20130904

DOCDB simple family (application)

US 2011057557 W 20111025; AU 2011320651 A 20111025; CA 2814703 A 20111025; EP 11836929 A 20111025